These laboratory methods can detect antibodies when the COVID-19 virus is present and long after infection is resolved, says KSL Chief Scientific Officer Long Shen. Antibody tests to identify people with immune response against COVID-19.Once ready, such technology would help to increase availability of tests and contribute to faster diagnosis of patients with active COVID-19 infections. The company has optimized its testing system to run up to 1,300 specimens a day, Lawson says. BIG funding was used to purchase sophisticated testing equipment that is facilitating this work. Testing for active COVID-19 infections.KSL Biomedical is conducting regulatory studies in its clinical laboratories to support launch of products and services in the United States and international markets. The company first deployed diagnostic technologies in the outbreak in China, and is seeking funding for deployment and scale-up in the U.S. “With the right partners, we can take these technologies further and help stem the outbreak wherever it spreads.” BIG has provided essential resources, positioning KSL to deliver practical solutions in New York State,” says KSL Biomedical CEO Kevin Lawson. “Experience has shown us that we need good information - accurate, high-capacity tests - to manage the COVID-19 outbreak and help people safely return to the workforce.
![ksl diagnostics ksl diagnostics](https://www.predictimmune.com/wp-content/uploads/2020/09/predictimmune-crohns-logo.jpg)
KSL has been engaged with the COVID-19 pandemic for months, with its senior management team traveling to China in January 2020 to work on projects there. Cuomo’s economic development effort to advance the Buffalo Niagara region as a center for bioinformatics and life sciences research. The company receives support from UB’s Buffalo Institute for Genomics and Data Analytics (BIG), part of Gov. UB partner company KSL Biomedical has developed diagnostic tests and is moving forward with clinical validation of prognostic tools that could improve patient care during the COVID-19 outbreak.